21-Sept-2026 18:47:12

SYMBIOTEC PHARMALAB ANNOUNCES BOARD MEETING OUTCOME

• The board of directors approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. • The trading window for dealing in the company's securities will remain closed until 48 hours from this announcement. • Information is available on the company's website. Impact: Board meeting outcome disclosed.

Symbiotec Pharmalab Limited

← Back to feed